drugset
drugset / Trial / NCT00918268

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects

NCT00918268 ↗

Phase 2 Completed 130 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Annual trial for registration influenza vaccine with the strain composition for season 2009/2010.

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 0.5 ml —

Indications

influenza